Kasper Sørensen (VentriJect)
Overview
Kasper Sørensen is a distinguished biomedical engineer and entrepreneur, most recognized as the co-founder and Chief Technology Officer (CTO) of VentriJect, a company that specializes in the development of the Seismofit® device. This innovative device leverages seismocardiography (SCG) to estimate VO2-max, offering a non-exercise method to gauge cardiorespiratory fitness. Sørensen's contributions to this field stem from his Ph.D. research at Aalborg University, where he focused on cardiomechanics and the use of seismocardiographic technology to enhance cardiovascular health diagnostics. He plays an instrumental role in the company's mission to integrate cardiorespiratory fitness measurement into routine health assessments on a global scale.
Recent Developments
- August 2025: VentriJect completed a Series A funding round, securing $1.98 million from investors including Vaekstfonden, Investo Capital, and TechStation. This funding aims to bolster VentriJect's expansion into the German, UK, and wider European markets, enhancing their digital and commercial strategy as they transition from MDD (Medical Device Directive) to MDR (Medical Device Regulation).
- 2023: Several studies have confirmed the validity and reliability of the Seismofit device. These studies underline the efficacy of SCG in providing accurate VO2-max estimations comparable to the traditional cardio-pulmonary exercise tests (CPET).
- 2024: An article published by Rekonnect highlighted VentriJect's approach in navigating the shift from MDD to MDR, outlining their commitment to maintaining compliance and innovating within regulatory frameworks.
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Kasper Sørensen |
| Born | Denmark (Exact date not publicly available) |
| Nationality | Danish |
| Occupation | Biomedical Engineer, Entrepreneur |
| Known For | Co-founding VentriJect and developing the Seismofit® device |
| Net Worth | Data Not Publicly Available |
| Education | Ph.D., Biomedical Engineering, Aalborg University |
| Languages Spoken | Danish, English |
Early Life and Education
Kasper Sørensen was born in Denmark, where he developed a passion for science and technology from an early age. His academic journey led him to Aalborg University, a hub for innovative research in Denmark. Graduating with a Bachelor's degree in Biomedical Engineering, he quickly escalated to a Master's, where he focused on signal processing, image analysis, and physiologic modeling. It was during his Ph.D. at the same university that Sørensen honed his expertise in seismocardiography, studying the mechanical contractions of the heart and its potential to monitor cardiovascular health non-invasively. His research was not only academically rigorous but also practical, paving the way for the creation of VentriJect.
Career and Notable Achievements
Kasper Sørensen's career is marked by his entrepreneurial spirit and dedication to advancing health technology:
- 2018: Co-founded VentriJect, a spin-off from Aalborg University, focusing on non-invasive measurement of VO2-max.
- 2021: Commercialized Seismofit®, gaining initial customers in Denmark and expanding into international markets.
- Published studies on SCG, cementing his reputation in the biomedical field.
- Continues to work as a CTO of VentriJect, driving innovation and regulatory compliance.
Current Work and Impact
Sørensen is currently steering VentriJect's growth as a leading health technology firm, focusing on the broader adoption of the Seismofit® device. His work emphasizes the importance of integrating cardiorespiratory fitness into everyday health practices, encouraging a shift towards preventative health care. The success of VentriJect under his leadership highlights the potential of SCG to revolutionize cardiovascular health diagnostics globally.
Conclusion
Kasper Sørensen's contributions to biomedical engineering and health technology are substantial. Through VentriJect, he has not only advanced the field of non-exercise cardiovascular diagnostics but has also shown how technological innovation can fundamentally change healthcare practices. His work continues to influence the global healthcare landscape, promoting healthier lifestyles and preventative medicine.